Previous 10 | Next 10 |
2023-05-08 13:32:43 ET Summary WisdomTree U.S. Value Fund ETF is an actively managed fund focused on dividends, buybacks and quality. It is well-diversified across sectors and holdings. The portfolio is greatly superior to the benchmark in valuation, and to a lesser extent in ...
NORTHAMPTON, MA / ACCESSWIRE / May 8, 2023 / Quest Diagnostics: Quest HealthConnect™ is dedicated to increasing access to quality extended care services that: Enable health plans and clinical providers to more effectively assess vulnerable patients and close critical gaps in care Help...
2023-05-04 07:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD Health PR Newswire The collaboration aims to help physicians improve detection and care of potentially treatable causes of cognitive decline SECAUCUS, N.J. and R...
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2023 / Quest Diagnostics On Thursday, April 13, Quest for Health Equity (Q4HE) collaborated with the Health Coalition of Passaic County (HCPC)'s Women's Health Task Force to host a community walk to raise awareness of health disparities among Black wome...
2023-04-27 14:57:18 ET Quest Diagnostics Incorporated (DGX) Q1 2023 Earnings Conference Call April 27, 2023 08:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Jim Davis - Chairman and Chief Executive Officer and President Sam Samad ...
2023-04-27 08:35:38 ET Quest Diagnostics ( NYSE: DGX ) is acquiring Haystack Oncology in an all-cash equity deal. Quest will pay Haystack — which is focused on minimal residual disease (MRD) testing for detection of residual or recurring cancer — &...
2023-04-27 06:47:15 ET Quest Diagnostics press release ( NYSE: DGX ): Q1 Non-GAAP EPS of $2.04 beats by $0.07 . Revenue of $2.33B (-10.7% Y/Y) beats by $130M . FY2023 revenue to be between $8.93b to $9.08B vs. consensus of $8.98B; adjusted diluted EPS expected ...
Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 PR Newswire First quarter revenues of $2.33 billion , down 10.7% from 2022 First quarter reported diluted earnings per share ("EPS") of $1.78 , down 39.0% from 2022;...
Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio PR Newswire Goal to improve patient outcomes through early, accurate detection of residual or recurring cancer Haystac...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...